GT201200216A - Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos. - Google Patents

Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos.

Info

Publication number
GT201200216A
GT201200216A GT201200216A GT201200216A GT201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A
Authority
GT
Guatemala
Prior art keywords
carboxamide
same
hydroxychinoline
new tertiary
tertiary derivatives
Prior art date
Application number
GT201200216A
Other languages
English (en)
Spanish (es)
Inventor
Del Sordo Simone
Gagliardi Stefania
Mailland Federico
Legora Michela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200216(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201200216A publication Critical patent/GT201200216A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GT201200216A 2009-12-29 2012-06-25 Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos. GT201200216A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (1)

Publication Number Publication Date
GT201200216A true GT201200216A (es) 2014-12-26

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200216A GT201200216A (es) 2009-12-29 2012-06-25 Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos.

Country Status (37)

Country Link
US (1) US8729098B2 (enExample)
EP (2) EP2345643A1 (enExample)
JP (1) JP5808754B2 (enExample)
KR (1) KR101666505B1 (enExample)
CN (2) CN102686566A (enExample)
AU (1) AU2010338267B2 (enExample)
BR (1) BR112012015728A2 (enExample)
CA (1) CA2783213C (enExample)
CL (1) CL2012001757A1 (enExample)
CY (1) CY1116493T1 (enExample)
DK (1) DK2519505T3 (enExample)
DO (1) DOP2012000186A (enExample)
EA (1) EA025563B1 (enExample)
EC (1) ECSP12012007A (enExample)
ES (1) ES2540327T3 (enExample)
GE (1) GEP20156244B (enExample)
GT (1) GT201200216A (enExample)
HR (1) HRP20150749T1 (enExample)
HU (1) HUE027220T2 (enExample)
IL (1) IL220427A (enExample)
MA (1) MA33829B1 (enExample)
MX (1) MX2012007748A (enExample)
MY (1) MY161869A (enExample)
NI (1) NI201200114A (enExample)
NZ (1) NZ600788A (enExample)
PE (1) PE20130179A1 (enExample)
PH (1) PH12012501326A1 (enExample)
PL (1) PL2519505T3 (enExample)
PT (1) PT2519505E (enExample)
RS (1) RS54096B1 (enExample)
SG (1) SG181586A1 (enExample)
SI (1) SI2519505T1 (enExample)
SM (1) SMT201500182B (enExample)
TN (1) TN2012000320A1 (enExample)
UA (1) UA107949C2 (enExample)
WO (1) WO2011080264A1 (enExample)
ZA (1) ZA201204347B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
CN104185624B (zh) * 2012-02-24 2016-10-12 弗·哈夫曼-拉罗切有限公司 抗病毒化合物
ES2749512T3 (es) 2012-10-02 2020-03-20 Inst Nat Sante Rech Med Derivados de tetrahidroquinolina y su uso como inhibidores de Epac
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation
CN220302508U (zh) 2020-09-22 2024-01-05 米沃奇电动工具公司 动力式紧固件驱动器及钉排
WO2022094190A2 (en) 2020-10-30 2022-05-05 Milwaukee Electric Tool Corporation Powered fastener driver

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326328A (en) 1885-09-15 Broiler
US326330A (en) 1885-09-15 Harness-support
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
US6194413B1 (en) * 1995-11-13 2001-02-27 Smithkline Beecham Corporation Hemoregulatory compounds
AU4172197A (en) 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
WO1999016747A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
EP1326865B1 (en) 2000-10-12 2009-05-06 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
CN1659143A (zh) 2001-03-01 2005-08-24 盐野义制药株式会社 具有hiv整合酶抑制活性的含氮杂芳基化合物
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
EP2059305A2 (en) * 2006-07-26 2009-05-20 Novartis Ag Inhibitors of undecaprenyl pyrophosphate synthase
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
UA102336C2 (uk) * 2009-11-10 2013-06-25 Пфайзер Інк. N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives

Also Published As

Publication number Publication date
MY161869A (en) 2017-05-15
IL220427A (en) 2015-04-30
CA2783213A1 (en) 2011-07-07
WO2011080264A1 (en) 2011-07-07
NZ600788A (en) 2013-08-30
EP2345643A1 (en) 2011-07-20
KR20120101563A (ko) 2012-09-13
GEP20156244B (en) 2015-02-10
AU2010338267B2 (en) 2014-03-27
PT2519505E (pt) 2015-09-03
SG181586A1 (en) 2012-07-30
US8729098B2 (en) 2014-05-20
CN102686566A (zh) 2012-09-19
EP2519505A1 (en) 2012-11-07
KR101666505B1 (ko) 2016-10-14
AU2010338267A2 (en) 2012-07-26
EA201270670A1 (ru) 2013-03-29
JP2013515755A (ja) 2013-05-09
US20120309751A1 (en) 2012-12-06
ECSP12012007A (es) 2012-08-31
HRP20150749T1 (hr) 2015-08-14
DOP2012000186A (es) 2013-01-15
MA33829B1 (fr) 2012-12-03
NI201200114A (es) 2013-04-22
PH12012501326A1 (en) 2015-04-01
MX2012007748A (es) 2012-08-03
HUE027220T2 (hu) 2016-10-28
SI2519505T1 (sl) 2015-08-31
JP5808754B2 (ja) 2015-11-10
ZA201204347B (en) 2013-09-25
PE20130179A1 (es) 2013-02-24
PL2519505T3 (pl) 2015-11-30
DK2519505T3 (en) 2015-06-29
CY1116493T1 (el) 2017-03-15
TN2012000320A1 (en) 2013-12-12
AU2010338267A1 (en) 2012-07-19
EP2519505B1 (en) 2015-05-27
EA025563B1 (ru) 2017-01-30
CN105384685A (zh) 2016-03-09
ES2540327T3 (es) 2015-07-09
CA2783213C (en) 2017-09-12
CL2012001757A1 (es) 2013-03-22
RS54096B1 (sr) 2015-10-30
SMT201500182B (it) 2015-09-07
BR112012015728A2 (pt) 2019-09-24
HK1178526A1 (en) 2013-09-13
UA107949C2 (xx) 2015-03-10

Similar Documents

Publication Publication Date Title
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
NI201400107A (es) Compuestos de heterociclilo como inhibidores de mek
MX2019003738A (es) Compuestos antivirales.
UY34917A (es) Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación
CR20150370A (es) Compuestos antivirales
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
GT201400063A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
UY35177A (es) Novedosos derivados de bencimidazol como antagonistas de ep4
MX2019010602A (es) Inhibidores de cdk.
ECSP14013215A (es) Compuestos novedosos
ECSP15012804A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
CR11623A (es) Compuestos
DOP2016000276A (es) 2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
ECSP11011391A (es) Métodos y productos intermedios para preparar agentes farmacéuticos
CR20140553A (es) Compuestos de fenoxietil piperidina
CU20150021A7 (es) Piridinonas bicíclicas novedosas
CR20140554A (es) Compuestos de acido dimetil-benzoico
MX2020004283A (es) Derivados de piridincarbonilo y usos terapéuticos de los mismos como inhibidores de trpc6.
UY32977A (es) Novedosos compuestos como inhibidores de la caseina quinasa
UY35551A (es) Derivados heteroarilos como inhibidores de aldosterona sintasa
ECSP11011485A (es) Espiro-epóxidos como productos intermedios.
ECSP11010992A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales